Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
57%(4 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
5
50%
Ph phase_3
1
10%
Ph phase_1
1
10%
Ph phase_2
3
30%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 31 (10.0%)
Phase 45 (50.0%)

Trials by Status

completed770%
terminated110%
withdrawn110%
unknown110%

Recent Activity

0 active trials
Showing 5 of 10
withdrawnphase_4

In Hospital IM Naltrexone: A Pilot Study

NCT05087771
unknownphase_2

Medication Maintenance Therapy in Community Pharmacy Settings

NCT04139213
completedphase_4

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings

NCT02978417
completedphase_2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

NCT00218426
completedphase_2

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

NCT01101815
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05087771Phase 4

In Hospital IM Naltrexone: A Pilot Study

Withdrawn
NCT04139213Phase 2

Medication Maintenance Therapy in Community Pharmacy Settings

Unknown
NCT02978417Phase 4

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings

Completed
NCT00218426Phase 2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Completed
NCT01101815Phase 2

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

Completed
NCT01377610Phase 1

Improved Strategies for Outpatient Opioid Detoxification

Completed
NCT00577408Phase 3

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

Completed
NCT01377168Phase 4

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

Completed
NCT01155869Phase 4

Pilot Study of Depot NTX in Homeless Veterans

Terminated
NCT00453804Phase 4

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10